Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: Unique viral latency in the tumour cells

British Journal of Cancer

Volumn 74, Issue 4, 1996, Pages 625-631

  Sugiura, M ^a   Imai, S ^a   Tokunaga, M ^b   Koizumi, S ^c   Uchizawa, M ^c   Okamoto, K ^c   Osato, T ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b Kagoshima City Hospital   (Japan)

^c Kin ikyo Chuo Hospital   (Japan)

Author keywords

Epstein Barr virus; Epstein Barr virus specific mRNA; Gastric carcinoma; Reverse transcription (RT) polymerase chain reaction analysis

Indexed keywords

MESSENGER RNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; IMMEDIATE EARLY GENE; MALE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CARCINOMA; VIRUS CARCINOGENESIS; VIRUS GENE; VIRUS LATENCY; VIRUS REPLICATION;

EID: 0029781040     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.412     Document Type: Article

References (52)

1. BROOKS L, YAO QY, RICKINSON AB AND YOUNG LS. (1992). Epstein Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts. J. Virol., 66, 2689-2697.
2. BROOKS LA, LEAR AL, YOUNG LS AND RICKINSON AB, (1993). Transcripts from the Epstein Barr virus BamHI A fragment are detectable in all three forms of virus latency. J. Virol., 67, 3182-3190.
3. BUSSON P, CCCOY R, SADLER R, GILLIGAN K, TURSZ T AND RAAB-TRAUB N. (1992). Consistent transcription of the Epstein - Barr virus LMP2 gene in nasopharyngeal carcinoma. J. Virol., 66, 3257-3262.
4. CHEN F, HU LF, ERNBERG I, KLEIN G AND WINBERG G. (1995). Coupled transcription of Epstein Barr virus latent membrane protein (LMP)-1 and LMP-2B genes in nasopharyngeal carcinomas. J. Gen. Virol., 76, 131-138.
5. COCHET C. MARTEL RD, GRUNEWALD V, BOSQ J, COCHET G, SCHWAAB G, BERNAUDIN JF AND JOAB I. (1993). Expression of the Epstein Barr virus immediate early gene, BZLF1, in nasopharyngeal carcinoma tumor cells. Virology, 197, 358-365.
6. COUNTRYMAN J, JENSON H, SEIBL R, WOLF H AND MILLER G. (1987). Polymorphic proteins encoded within BZLF1 of defective and standard Epstein Barr viruses disrupt latency. J. Virol., 61, 3672-3679.
7. DAWSON CW, RICKINSON AB AND YOUNG LS. (1990). Epstein Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature, 344, 777-780.
8. DEACON EM, PALLESEN G, NIEDOBITEK G, CROCKER J, BROOKS L, RICKINSON AB AND YOUNG LS. (1993). Epstein- Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. J. Exp. Med., 177, 339-349.
9. DIMERY IW, LEE JS, BLICK M, PEARSON G, SPITZER G AND HONG WK. (1988). Association of the Epstein-Barr virus with lymphoepithelioma of the thymus. Cancer, 61, 2475-2480.
10. FÅHRAEUS R, RYMO L, RHIM JS AND KLEIN G. (1990). Morphological transformation of human keratinocytes expressing the LMP gene of Epstein Barr virus. Nature, 345, 447-449.
11. GILLIGAN K, SATO H, RAJADURAI P, BUSSON P, YOUNG L, RICKINSON A, TURSZ T AND RAAB-TRAUB N. (1990). Novel transcription from the Epstein Barr virus terminal EcoRI fragment, DIJhet, in a nasopharyngeal carcinoma. J. Virol., 64, 4948-4956.
12. GREENSPAN JS, GREENSPAN D, LENNETTE ET, ABRAMS DI, CONANT MA, PETERSEN V AND FREESE UK. (1985). Replication of Epstein - Barr virus within the epithelial cells of oral 'hairy' leukoplakia, an AIDS-associated lesion. N. Engl. J. Med., 313, 1564-1571.
13. HARABUCHI Y, YAMANAKA N, KATAURA A, IMAI S, KINOSHITA T, MIZUNO F AND OSATO T. (1990). Epstein - Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet, 335, 128-130.
14. HERBST H, DAELENBACH F, HUMMEL M, NIEDOBITEK G, PILERI S, MULLER LN AND STEIN H. (1991). Epstein - Barr virus latent membrane protein expression in Hodgkin and Reed Sternberg cells. Proc. Natl Acad. Sci. USA, 88, 4766-4770.
15. IMAI S, KOIZUMI S, SUGIURA M, TOKUNAGA M, UEMURA Y, YAMAMOTO N, TANAKA S, SATO E AND OSATO T. (1994). Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein - Barr virus latent infection protein. Proc. Natl Acad. Sci. USA, 91, 9131-9135.
16. KERR BM, LEAR AL, ROWE M, CROOM CD, YOUNG LS, ROOKES SM, GALLIMORE PH AND RICKINSON AB. (1992). Three transcriptionally distinct forms of Epstein - Barr virus latency in somatic cell hybrids: cell phenotype dependence of virus promoter usage. Virology, 187, 189-201.
17. KHANNA R, BURROWS SR, KURILLA MG, JACOB CA, MISKO IS, SCULLEY TB, KIEFF E AND MOSS DJ. (1992). Localization of Epstein - Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development. J. Exp. Med., 176, 169-176.
18. KLEIN G, LINDAHL T, JONDAL M, LEIBOLD W, MENEZES J, NILSSON K AND SUNDSTRÖM C. (1974). Continuous lymphoid cell lines with characteristics of B cells (bone marrow-derived), lacking the Epstein - Barr virus genome and derived from three human lymphomas. Proc. Natl Acad. Sci. USA, 71, 3283-3286.
19. KORBJUHN P, ANAGNOSTOPOULOS I, HUMMEL M, TIEMANN M, DALLENBACH F, PARWARESCH MR AND STEIN H. (1993). Frequent latent Epstein Barr virus infection of neoplastic T cells and bystander B cells in human immunodeficiency virus-negative European peripheral pleomorphic T-cell lymphomas. Blood, 82, 217-223.
20. LEAR AL, ROWE M, KURILLA MG, LEE S, HENDERSON S, KIEFF E AND RICKINSON AB. (1992). The Epstein - Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle. J. Virol., 66, 7461-7468.
21. LEVITSKAYA J, CORAM M, LEVITSKY V, IMREH S, STEIGERWALD-MULLEN PM, KLEIN G, KURILLA MG AND MASUCCI MG. (1995). Inhibition of antigen processing by the internal repeat region of the Epstein - Barr virus nuclear antigen-1. Nature, 375, 685-688.
22. LEYVRAZ S, HENLE W, CHAHINIAN AP, PERLMANN C, KLEIN G, GORDON RE, ROSENBLUM M AND HOLLAND JF. (1985). Association of Epstein - Barr virus with thymic carcinoma. N. Engl. J. Med., 312, 1296-1299.
23. LI QX, YOUNG LS, NIEDOBITEK G, DAWSON CW, BIRKENBACH M, WANG F AND RICKINSON AB. (1992). Epstein - Bar virus infection and replication in a human epithelial cell system. Nature, 356, 347-350.
24. LIEBOWITZ D AND KIEFF E. (1993). Epstein - Barr virus. In The Human Herpesviruses. Roizman B, Whitley RJ and Lopez C. (eds) pp. 107-172. Raven Press: New York.
25. MILLER G AND LIPMAN M. (1973). Release of infectious Epstein - Barr virus by transformed marmoset leukocytes. Proc. Natl Acad. Sci. USA, 70, 190-194.
26. MILLER CL, LONGNECKER R AND KIEFF E. (1993). Epstein - Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes. J. Virol., 67, 3087-3094.
27. MILLER CL, LEE JH, KIEFF E AND LONGNECKER R. (1994). An integral membrane protein (LMP2) blocks reactivation of Epstein - Barr virus from latency following surface immunoglobulin crosslinking. Proc. Natl Acad. Sci. USA, 91, 772-776.
28. MILLER WE, EARP HS AND RAAB-TRAUB N. (1995). The Epstein - Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor. J. Virol., 69, 4390-4398.
29. MOSS DJ, CHAN SH, BURROWS SR, CHEW TS, KANE RG, STAPLES JA AND KUNARATNAM N. ( 1983). Epstein - Barr virus specific T-cell response in nasopharyngeal carcinoma patients. Int. J. Cancer, 32, 301-305.
30. MURRAY RJ, KURILLA MG, BROOKS JM, THOMAS WA, ROWE M, KIEFF E AND RICKINSON AB. (1992). Identification of target antigens for the human cytotoxic T cell response to Epstein - Barr virus (EBV): implications for the immune control of EBV-positive malignancies. J. Exp. Med., 176, 157-168.
31. NIEDOBITEK G, HERBST H, YOUNG LS, ROWE M, DIENEMANN D, GERMER C AND STEIN H. (1992). Epstein - Barr virus and carcinomas. Expression of the viral genome in an undifferentiated gastric carcinoma. Diag. Mol. Pathol., 1, 103 - 108.
32. NONKWELO C, SKINNER J, BELL A, RICKINSON A AND SAMPLE J. (1996). Transcription start sites downstream of the Epstein - Barr virus (EBV) Fp promoter in early-passage Burkitt's lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein. J. Virol., 70, 623-627.
33. ODA K, TAMARU J, TAKENOUCHI T, MIKATA A, NUNOMURA M, SAITOH N, SARASHINA H AND NAKAJIMA N. (1993). Association of Epstein - Barr virus with gastric carcinoma with lymphoid stroma. Am. J. Pathol., 143, 1063-1071.
34. PALLESEN G, HAMILTON DS, ROWE M AND YOUNG LS. (1991). Expression of Epstein - Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet, 337, 320-322.
35. PATTON DF, RIBEIRO RC, JENKINS JJ AND SIXBEY JW. (1994). Thymic carcinoma with a defective Epstein - Barr virus encoding the BZLF1 trans-activator. J. Infect. Dis., 170, 7-12.
36. QU L AND ROWE DT. (1992), Epstein - Barr virus latent gene expression in uncultured peripheral blood lymphocytes. J. Virol., 66, 3715-3724.
37. ROGERS RP, WOISETSCHLAEGER M AND SPECK SH. (1990). Alternative splicing dictates translational start in Epstein - Barr virus transcripts. EMBO J., 9, 2273-2277.
38. ROONEY CM, RICKINSON AB, MOSS DJ, LENOIR GM AND EPSTEIN MA. (1985). Cell-mediated immunosurveillance mechanisms and pathogenesis of Burkitt's lymphoma. IARC Scient. Publ., 60, 249-264.
39. ROWE M, ROWE DT, GREGORY CD, YOUNG LS, FARRELL PJ, RUPANI H AND RICKINSON AB. (1987). Differences in B cell growth phenotype reflect novel patterns of Epstein - Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J., 6, 2743-2751.
40. SAMPLE J, BROOKS L, SAMPLE C, YOUNG L, ROWE M, GREGORY C, RICKINSON A AND KIEFF E. (1991). Restricted Epstein - Barr virus protein expression in Burkitt lymphoma is due to a different Epstein Barr nuclear antigen 1 transcriptional initiation site. Proc. Natl Acad. Sci. USA, 88, 6343-6347.
41. SCHAEFER BC, WOISETSCHLAEGER M, STROMINGER JL AND SPECK SH. (1991). Exclusive expression of Epstein Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes. Proc. Natl Acad. Sci. USA, 88, 6550-6554.
42. SCHAEFER BC, STROMINGER JL AND SPECK SH. (1995a). Redefining the Epstein Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines. Proc. Natl Acad. Sci. USA, 92, 10565-10569.
43. SCHAEFER BC, STROMINGER JL AND SPECK SH. (1995b). The Epstein - Barr virus BamHI F promoter is an early lytic promoter: lack of correlation with EBNA 1 gene transcription in group I Burkitt's lymphoma cell lines. J. Virol., 69, 5039-5047.
44. SHIBATA D, TOKUNAGA M, UEMURA Y, SATO E, TANAKA S AND WEISS LM. (1991). Association of Epstein - Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration. Lymphoepithelioma-like carcinoma. Am. J. Pathol., 139, 469-474.
45. SHIMIZU N, TANABE-TOCHIKURA A, KUROIWA Y AND TAKADA K. (1994). Isolation of Epstein - Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV. J. Virol., 68, 6069-6073.
46. SIXBEY JW AND YAO QY. (1992). Immunoglobulin A-induced shift of Epstein - Barr virus tissue tropism. Science, 255, 1578-1580.
47. SU IJ, HSIEH HC, LIN KH, UEN WC, KAO CL, CHEN CJ, CHENG AL, KADIN ME AND CHEN JY. (1991). Aggressive peripheral T-cell lymphomas containing Epstein - Barr viral DNA: a clinicopathologic and molecular analysis. Blood, 77, 799-808.
48. TAKADA K AND ONO Y. (1989). Synchronous and sequential activation of latently infected Epstein - Barr virus genomes. J. Virol., 63, 445-449.
49. TIERNEY RJ, STEVEN N, YOUNG LS AND RICKINSON AB. (1994). Epstein - Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J. Virol., 68, 7374-7385.
50. WANG D, LIEBOWITZ D AND KIEFF E. (1985). An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell, 43, 831-840.
51. YOUNG L, ALFIERI C, HENNKSSY K, EVANS H, O'HARA C, ANDERSON KC, RITZ J, SHAPIRO RS, RICKINSON A, KIEFF E AND COHEN JI. (1989). Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N. Engl. J. Med., 321, 1080-1085.
52. YOUNG LS, LAU R, ROWE M, NIEDOBITEK G, PACKHAM G, SHANAHAN F, ROWE DT, GREENSPAN D, GREENSPAN JS, RICKINSON AB AND FARREL PJ. (1991). Differentiation-associated expression of the Epstein Barr virus BZLFI transactivator protein in oral hairy leukoplakia. J. Virol., 65, 2868-2874.